首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
【24h】

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

机译:术前放化疗联合全直肠系膜切除术治疗直肠癌患者的辅助化疗:荷兰结肠直肠癌组(DCCG)随机III期试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The discussion on the role of adjuvant chemotherapy for rectal cancer patients treated according to current guidelines is still ongoing. A multicentre, randomized phase III trial, PROCTOR-SCRIPT, was conducted to compare adjuvant chemotherapy with observation for rectal cancer patients treated with preoperative (chemo) radiotherapy and total mesorectal excision (TME).
机译:背景:关于根据当前指南治疗的直肠癌患者辅助化疗作用的讨论仍在进行中。进行了一项多中心,随机,III期试验,PROCTOR-SCRIPT,以比较辅助化疗与术前(化学)放疗和全直肠系膜切除术(TME)治疗的直肠癌患者的观察结果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号